# Hans‐Henrik Parving

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/hans-henrik-parving/

## Facts

| Field | Value |
| --- | --- |
| Citations | 26,342 |
| Field | Chronic Kidney Disease and Diabetes |
| h-index | 61 |
| i10-index | 109 |
| Last Known Institution | University of Copenhagen |
| OpenAlex ID | https://openalex.org/A5109208822 |
| Works | 142 |

## Researcher papers

Showing 12 of 13.

- [Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy](https://scholariq.org/papers/effects-of-losartan-on-renal-and-cardiovascular-outcomes-in-patients-with-type-2/)
- [Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes](https://scholariq.org/papers/multifactorial-intervention-and-cardiovascular-disease-in-patients-with-type-2/)
- [Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis](https://scholariq.org/papers/rosuvastatin-and-cardiovascular-events-in-patients-undergoing-hemodialysis/)
- [Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study](https://scholariq.org/papers/intensified-multifactorial-intervention-in-patients-with-type-2-diabetes/)
- [Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL](https://scholariq.org/papers/proteinuria-a-target-for-renoprotection-in-patients-with-type-2-diabetic/)
- [Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy](https://scholariq.org/papers/albuminuria-a-therapeutic-target-for-cardiovascular-protection-in-type-2/)
- [Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial](https://scholariq.org/papers/selective-vitamin-d-receptor-activation-with-paricalcitol-for-reduction-of/)
- [Effect of antihypertensive treatment on kidney function in diabetic nephropathy.](https://scholariq.org/papers/effect-of-antihypertensive-treatment-on-kidney-function-in-diabetic-nephropathy/)
- [Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial](https://scholariq.org/papers/years-of-life-gained-by-multifactorial-intervention-in-patients-with-type-2/)
- [Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study](https://scholariq.org/papers/risk-factors-for-development-of-incipient-and-overt-diabetic-nephropathy-in/)
- [Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy](https://scholariq.org/papers/renoprotective-effects-of-angiotensin-ii-receptor-blockade-in-type-1-diabetic/)
- [Aldosterone escape during blockade of the renin?angiotensin?aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate](https://scholariq.org/papers/aldosterone-escape-during-blockade-of-the-renin-angiotensin-aldosterone-system/)

## Researcher topics

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Renin-Angiotensin System Studies](https://scholariq.org/topics/renin-angiotensin-system-studies/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)

## Researcher university

- [University of Copenhagen](https://scholariq.org/institutions/university-of-copenhagen/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
